SPD-554

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSPD-554
Drug Alias NameSPD-554
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAutistic DisorderAttention Deficit Disorder with HyperactivityAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAutistic DisorderAttention Deficit Disorder with HyperactivityAnxiety

Other Information

ATC CodeN/A
Related LinksN/A